WealthSource Partners’s Abiomed Inc ABMD Stock Holding History

WealthSource Partners’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-742	Closed	-$246K	–	617
2022 Q1	$246K	Sell	742 -5	-0.7%	-$1.54K	0.02%	498
2021 Q4	$268K	Sell	747 -3	-0.4%	-$1.01K	0.02%	459
2021 Q3	$244K	Buy	750 +20	+3%	+$6.78K	0.02%	444
2021 Q2	$228K	Sell	730 -30	-4%	-$9.2K	0.02%	419
2021 Q1	$242K	Buy	+760	New	+$243K	0.02%	375
2019 Q2	–	Sell	-838	Closed	-$239K	–	492
2019 Q1	$239K	Sell	838 -20	-2%	-$6.65K	0.05%	302
2018 Q4	$279K	Sell	858 -239	-22%	-$83K	0.08%	225
2018 Q3	$493K	Buy	1,097 +210	+24%	+$82.8K	0.13%	153
2018 Q2	$363K	Buy	887 +175	+25%	+$63.4K	0.1%	185
2018 Q1	$207K	Buy	+712	New	+$180K	0.06%	265

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WealthSource Partners's ABMD Position: Q2 2022 in Review

WealthSource Partners sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 742 shares — an estimated $246K sold.

WealthSource Partners first reported a position in ABMD in Q1 2018 and held it in 10 quarters. The position peaked at $493K in Q3 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

WealthSource Partners reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
WealthSource Partners sold 742 Abiomed Inc shares in Q2 2022, an estimated $246K.
WealthSource Partners first reported a position in Abiomed Inc in Q1 2018 and held it in 10 quarters.
WealthSource Partners's Abiomed Inc position peaked at $493K in Q3 2018.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on WealthSource Partners's 13F filing for Q2 2022, filed 10 Aug 2022.